Psoriatic Arthritis Treatment Market Report 2026

Psoriatic Arthritis Treatment Market Overview

• Psoriatic Arthritis Treatment market size has reached to $13.17 billion in 2025 • Expected to grow to $20.62 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Rising Healthcare Spending Boosts Prospects In The Psoriatic Arthritis Treatment Market • Market Trend: New Drug Approvals Propel Psoriatic Arthritis Treatment Market Growth • North America was the largest region in 2025.

What Is Covered Under Psoriatic Arthritis Treatment Market?

Psoriatic arthritis treatment refers to a method of treatment or drug used to stop or lessen a chronic inflammatory disease of the joints and the areas where tendons and ligaments attach to the bones (entheses). This treatment focuses on controlling skin involvement and treating joint pain and disability. The main classes of drugs in psoriatic arthritis treatment are nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), biologics, and others. A biological medicine (biologics) is a substance that is made from or contains living organism components. The different routes of administration include oral, parenteral, and topical, and they are distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Psoriatic Arthritis Treatment Market Growth Forecast?

The psoriatic arthritis treatment market size is expected to see strong growth in the next few years. It will grow to $20.62 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to development of interleukin inhibitors and jak inhibitors, increasing adoption of biologics, growth of personalized medicine approaches, rising telemedicine adoption for chronic disease management, increasing government and insurance support for psoriatic arthritis treatment. Major trends in the forecast period include rising adoption of biologics and targeted synthetic dmards, increased awareness of early diagnosis and management of psoriatic arthritis, growth in personalized treatment approaches for joint and skin symptoms, expansion of hospital and specialty pharmacy distribution channels, integration of telemedicine and remote monitoring for psoriatic arthritis patients.

Global Psoriatic Arthritis Treatment Market Segmentation

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologics, Other Drug Classes 2) By Route Of Administration: Oral, Parenteral, Topical 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, COX-2 Inhibitors 2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted Synthetic DMARDs 3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Other Biologics 4) By Other Drug Classes: Corticosteroids, Topical Treatments, Janus Kinase (JAK) Inhibitors

What Is The Driver Of The Psoriatic Arthritis Treatment Market?

The increase in healthcare spending is expected to propel the growth of the psoriatic arthritis treatment market going forward. Healthcare spending, also known as healthcare expenditure, refers to the financial resources allocated to support the provision of healthcare services, products, and programs within a specific country, region, or healthcare system. Healthcare spending supports the diagnostic process by funding medical appointments, laboratory tests, and imaging studies. Patients with PsA often undergo a comprehensive evaluation to confirm the diagnosis, determine the extent of joint involvement, and assess any associated comorbidities. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the increase in healthcare spending is driving the growth of the psoriatic arthritis treatment industry.

Key Players In The Global Psoriatic Arthritis Treatment Market

Major companies operating in the psoriatic arthritis treatment market are AbbVie Inc., Amgen Astellas BioPharma K.K., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., Merck & Co. Inc., AstraZeneca plc, Sanofi SA, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Bayer AG, Eisai Inc., Janssen Pharmaceuticals Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Chugai Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd.

Global Psoriatic Arthritis Treatment Market Trends and Insights

Major companies operating in the psoriatic arthritis treatment market are receiving approvals for new drugs such as Cosentyx to increase their profitability in the market. Cosentyx is a drug used to treat autoimmune diseases such as non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and enthesitis-related arthritis. For instance, in October 2023, Novartis, a Switzerland-based pharmaceutical company announced that the Food and Drug Administration had approved its new drug Cosentyx. Cosentyx is a human interleukin-17A antagonist that functions by preventing the activation of a protein called IL-17A, which lessens potential patient side effects such as edema, discomfort, and skin rashes. Cosentyx has been shown to help with the symptoms of psoriatic arthritis and can begin to act in as little as three weeks. It relieves several psoriatic arthritis symptoms, such as joint pain and tenderness, back discomfort, and skin problems.

What Are Latest Mergers And Acquisitions In The Psoriatic Arthritis Treatment Market?

In February 2023, Takeda Pharmaceutical Company, a Japan-based pharmaceutical company, acquired Nimbus Therapeutics for an undisclosed amount. The acquisition is anticipated to improve Takeda Pharmaceutical's position in the market for psoriatic arthritis treatments and broaden its product line. Nimbus Therapeutics is a US-based biotechnology company. It develops drugs for psoriatic arthritis treatment.

Regional Insights

North America was the largest region in the psoriatic arthritis treatment market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Psoriatic Arthritis Treatment Market?

The psoriatic arthritis treatment market includes revenues earned by entities by reducing pain and swelling and controlling inflammation and pain. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Psoriatic Arthritis Treatment Market Report 2026?

The psoriatic arthritis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the psoriatic arthritis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.